SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Politics for Pros- moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: frankw1900 who wrote (722720)8/1/2020 9:34:07 PM
From: skinowski3 Recommendations

Recommended By
i-node
lightshipsailor
Pogeu Mahone

  Read Replies (1) of 794008
 
The differences between HCQ / Zithromax and Ivermectin / Doxycycline were not statistically significant. Basically, these differences are not something to rely on. Could be noise.

For prophylaxis, it seems that HCQ is better - due to a much longer half life, which is about a month, could be longer. For ivermectin, it’s measured in hours.

Could turn out that HCQ is better for prophylaxis - but ivermectin - for treatment, for those who would still get infected. (Which, btw, would suggest a failure of HCQ to prevent the disease in the first place - yet another reason to consider Ivermectin). On the down side, there is a lot more data on HCQ.

Fauci... couldn’t recruit more than 20 patients in the midst of a pandemic?? Out of millions of infected people? Probably didn’t try hard enough. Didiert and Zelenko had no problems finding patients.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News